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Abstract
Background: To investigate antibiotic resistance, the occurrence and distribution of class 1 and 2 integrons in
multidrug- resistant Staphylococcus aureus isolates from hospitals in Tehran, Iran.
The isolates were examined for susceptibility to antimicrobial agents. The mecA gene, class 1 and 2 integrons were
detected by PCR. Integrase positive strains were further analysed for the presence of resistance gene cassettes
using specific primers and were sequenced.
Results: Among 139 S.aureus isolates, 109 (78.4 %) and 112 (80.5 %) strains were considered as multidrug resistant
and mecA positive, respectively. Class 1 integrons and internal variable regions were found in 72.6 % (101/139) and
97 % (98/101) and class 2 integrons and variable regions also in 35.2 % (49/139) and 65.3 % (32/49) of S.aureus
clinical isolates, respectively. Twelve distinct cassette arrays were found, containing genes encoding resistance to
β-lactams, aminoglycosides, streptothricin, trimethoprim, chloramphenicol,a putative glucose dehydrogenase
precursor and a protein with unknown function. Gene cassette arrays aadB, aadA2 and dhfrA1-sat2-aadA1 were
common in S.aureus isolates. We detected a completely new gene cassettes which contained aadB, oxa2, aacA4,
orfD-aacA4-catB8, aadB-catB3, orfD-aacA4 and aadB-aadA1-cmlA6 of class 1 and dhfrA1-sat2-aadA1, dhfrA11,
dhfrA1-sat2 of class 2 integrons.
Conclusions: This is the first study to report carriage of class 1 and 2 integrons and associated gene cassettes
among in S.aureus isolates from Iran.
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Background
Staphylococcus aureus has long been recognized as a
major human pathogen responsible for a wide range of
infections, from mild skin infections to wound infections
and bacteraemia [1]. Although the introduction of antibi-
otics has lowered the mortality rate from S. aureus infec-
tions, the bacteria have developed resistance mechanisms
to all antimicrobial agents that have been produced [1].
Despite antibiotic therapy, staphylococcal infections
occur regularly in hospitalized patients and have severe
consequencess [2, 3]. Due to an increasing number of
infections caused by methicillin-resistant S. aureus
(MRSA) strains, which are now most often multiresis-
tant, therapy has become problematic [4]. Since this or-
ganism can spread easily by direct or indirect contact
between patients and the environment, or among pa-
tients and medical personnel, S. aureus is an important
cause of nosocomial infection, and major outbreaks are
common [5, 6].
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Dissemination of antibiotic resistance genes by hori-
zontal gene transfer has led to the rapid emergence of
antibiotic resistance among bacteria, thus complicating
the treatment of infections [7]. Acquired resistance
evolves via horizontal transfer of antimicrobial resistance
genes located on various types of mobile DNA elements.
A key system involved in spreading antibiotic multiresis-
tance is the integron, an element that, although normally
immobile itself, can be transferred through mobile gen-
etic elements [8, 9]. Integrons are genetic elements that
incorporate exogenous open reading frames by recom-
bination and convert them to functional genes [10]. All
integrons characterized to date are composed of these
major elements: a gene (intI) encoding an integrase; a
primary recombination site (attI); and an outward orien-
tated promoter (Pc) that directs transcription of the cap-
tured genes [11].
In this study, the presence of integrons and gene cas-
settes in S. aureus has been studied for the first time in
Iran.
The objective of this research was to identified mul-
tiple drug resistance in clinical isolates of s. aureus by
antibiotic sensitivity testing, detection of mecA gene for
methicillin-resistant S. aureus strains, and distribution of
class 1 and 2 integrons and associated gene cassettes
among S.aureus isolates collected from clinical sources
in Tehran by PCR assays and investigates associations
between multidrug resistance and the existence of
integrons.
Methods
Sampling and bacterial isolation
One hundred and thirty nine S. aureus isolates were col-
lected from hospitals in Tehran, over a six month period,
starting from the first of October 2011 till the end of March
2012 . The isolates were recovered from wounds (n = 31),
blood (n = 31), urines (n = 28), nasal swabs (n = 21),
catheters (n = 5), sternum samples (n = 5), sputa (n = 4),
eyes (n = 2), CSF (n = 1), synovial fluid (n = 1), throat sam-
ples (n = 3) and abscesses (n = 7). The isolates were identi-
fied as S. aureus by standard biochemical tests for
catalase, coagulase, clumping factor, DNase, and thermo-
stable nuclease. All isolates were also evaluated for the
presence of the sa442 gene by PCR [3, 12]. The research
was approved by the Ethics committee of the Pasteur In-
stitute of Iran (no = 402) and acquire either verbal or writ-
ten informed consent from the patients to take their
samples for this study.
Antibiotic susceptibility test
The isolated S. aureus strains were tested for their in vitro
antimicrobial susceptibility using the disk diffusion tech-
nique on Mueller- Hinton agar (Mast, UK). The results
were recorded after 18 h of incubation at 37єC.
Antimicrobial drugs tested included Penicillin G;
PG(30 μg), Amoxicillin; A(25 μg), Linezolid; LZD(30 μg),
Streptomycine; S(10 μg), Ampicillin; AP(10 μg),
Tetracycline; T(30 μg), Chloramphenicol; C (30 μg),
Sulfamethoxazole-Trimethoprim; SXT(30 μg), Amikacin;
AK(30 μg), Azithromycin; ATH(15 μg), Spectinomycin;
SPC(100 μg), Gentamicin; GM(10 μg), Vancomycin;
VA(30 μg), Teicoplanin; TEC(30 μg), Ciprofloxacin;
CIP(5 μg), Oxacillin; OX(1 μg), Levofloxacin; LEV(5 μg),
Gatifloxacin; GAT(5 μg), Rifampin; RP(5 μg), Erythro-
mycin; E(15 μg), Ceftriaxone; CRO(30 μg), Tobramycin;
TN(10 μg), Clindamycin; CD(2 μg) . The MIC to vanco-
mycin was determined by Etest (bioMeґrieux). Entero-
coccus faecalis ATCC 29212 and Enterococcus faecium
BM4147 were used as controls for vancomycin suscepti-
bility and vancomycin resistance, respectively. The break-
points for antibiotic susceptibility were determined
according to the guidelines of the Clinical and Laboratory
Standards Institute (CLSI) [13]. E. coli ATCC 25922 was
used as a reference control strain. Isolates of S.aureus that
show resistance to three or more than three classes of an-
tibiotics, considered as multidrug – resistant strains.
The extraction of S. aureus plasmid and genomic DNA
The genomic DNA preparation used in this study was
performed following Sambrook et al. [14]. The DNA was
extracted with phenol-chloroform and precipitated by
ice-cold ethanol. The DNA pellet was washed with 70 %
ethanol and resuspended in 50 μl of TE buffer (10 mM
Tris; 1 mM EDTA, pH8) and stored at -20єC until used
and 1 μl of the suspension were used as the template
DNA for PCR. Using the primers determined [3] mecA
gene was detected by PCR. Size of the amplified frag-
ment was 533 bp.
The Qiagen Plasmid Midi Kit was used for the S. aur-
eus plasmid DNA extraction; the manufacturer’s instruc-
tions were followed.
Detection of class 1 and 2 integrons
All isolates were screened for detection of class 1 and 2
integrons by the primers described by Moura et al. [15] de-
signed for the intI1 and intI2 genes respectively. Primers
intI1 F/R and intI2 F/R were used to amplify 280 bp and
232 bp fragments, respectively. The amplification program
was performed by termocycler (Eppendorf Mastercycler®,
MA) and started with initial denaturation of 4 min at 94 °C
and programmed wi th 35 cycles of each: 1 min at 94 °C,
30 s at 55 °C, 1 min at 72 °C. The program finished with
the final extension of 10 min at 72 °C.
Mapping of class 1 and 2 integrons
The gene cassettes inserted in the variable regions of
class 1 and 2 integrons (IVR) were amplified using the
primer pairs introduced by Moura et al. [15].
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Sequencing of amplified integron gene cassettes
For each PCR product that had a unique size when vi-
sualized on the gel, a number of samples of the post-
PCR mixture was processed with the High Pure PCR
Product Purification kit (Roche,USA) and used for dir-
ect sequencing. The purified amplicons were sequenced
using the ABI Capillary System (Pasteur Institute,
Tehran, Iran). Resulting sequences were assembled by
using SeqMan program within the Lasergene suite ver-
sion 7 (DNAstar Inc, Madison, WI, USA). Potential
open reading frames (ORFs) were predicted by using
the NCBI (National Center for Biotechnology Informa-
tion) ORF Finder tool (http://www.ncbi.nlm.nih.gov/
gorf/gorf.html). BLAST (http://blast.ncbi.nlm.nih.gov/
Blast.cgi) against GenBank database and The Integron
Database INTEGRALL (http://integrall.bio.ua.pt/) were
performed repeatedly for sequence comparison and
annotation.
Statistical analysis
The antibiotic resistance data between integron-positive
isolates and integron-negative isolates was compared
and the χ2 test was used to calculate the P value in
terms of resistant and susceptible numbers by SPSS
version 18 software. A P value of <0.05 was considered
statistically significant.
Results
A total of 139 S. aureus isolates were collected from clin-
ical specimens of hospitals in Tehran, over a 6 month
period, starting from the first of October 2011 till the
end of March 2012.
Antibiotic susceptibility test
The antimicrobial resistance patterns of isolates are
shown in Tables 1 and 2. According to the results of the
vancomycin Etest, all isolates were susceptible to this
agent. Of the 139 isolates, 109 (78.4 %) isolates were
designated as MDR S.aureus. Overall, 112 (80.5 %) iso-
lates were resistant to methicillin and were confirmed as
MRSA based on the detection of the mecA gene. Distri-
bution of mecA gene in MRSA isolates from nosocomial
sources are shown in Fig. 1. All of the MRSA isolates
were susceptible to Vancomycin and Teicoplanin
(100 %). Also all MRSA isolates were resistant to Amoxi-
cillin (100 %) and Ampicillin (100 %), Tetracycline 69
(61.6 %), Amikacin 40 (35.7 %), Ceftriaxone 68 (60.7 %),
Gentamicin 73 (65.1 %), Spectinomycin 77 (68.7 %),
Table 1 Correlation of antibiotic resistance between class 1 integron-positive and integron-negative of S.aureus
Antibiotics All strains of S.aureus (n = 139) Integron-positive isolates (n = 101) Integron-negative isolates (n = 38) P
valueR S R S R S
AK* 43 (31 %) 96 (69 %) 35 (34.7 %) 66 (25.3 %) 8 (21 %) 30 (79 %) 0.088
SXT* 38 (27.3 %) 101 (72.7 %) 34 (33.7 %) 67 (66.3 %) 4 (10.5 %) 34 (89.5 %) 0.004
C* 49 (32.3 %) 90 (64.7 %) 41 (40.6 %) 60 (59.4 %) 8 (21 %) 30 (79 %) 0.024
TE* 78 (56.1 %) 61 (43.9 %) 65 (64.4 %) 36 (35.6 %) 13 (34.2 %) 25 (65.8 %) 0.001
CIP* 56 (40.3 %) 83 (59.7 %) 49 (48.5 %) 52 (51.5 %) 7 (18.4 %) 31 (81.6 %) 0.001
GM* 76 (54.7 %) 63 (45.3 %) 68 (67.3 %) 33 (32.7 %) 8 (21 %) 30 (79 %) <0.001
SPC* 86 (61.9 %) 53 (38.1 %) 73 (72.3 %) 28 (27.7 %) 13 (34.2 %) 25 (65.8 %) <0.001
ATH* 69 (49.6 %) 70 (50.4 %) 62 (61.4 %) 39 (38.6 %) 7 (18.4 %) 31 (81.6 %) <0.001
S* 75 (54 %) 64 (46 %) 61 (60.4 %) 40 (39.6 %) 14 (37 %) 24 (63 %) 0.011
GAT 44 (31.7 %) 95 (68.3 %) 32 (31.7 %) 69 (68.3 %) 12 (31.6 %) 26 (68.4 %) 0.581
OXA 104 (74.8 %) 35 (25.2 %) 76 (75.2 %) 25 (24.8 %) 28 (73.7 %) 10 (26.3 %) 0.505
PG 137 (98.6 %) 2 (1.4 %) 101 (100 %) 0 (0 %) 36 (94.7 %) 2 (5.3 %) 0.073
RP 43 (31 %) 96 (69 %) 31 (30.7 %) 70 (69.3 %) 12 (31.6 %) 26 (68.4) 0.537
LZD 24 (17.3 %) 115 (82.7 %) 20(19.8 %) 81 (80.2 %) 4 (10.5 %) 34 (89.5 %) 0.149
CD 84 (60.4 %) 55 (39.6 %) 65 (64.4 %) 36 (35.6 %) 19 (50 %) 19 (50 %) 0.089
E* 95 (68.3 %) 44 (31.7 %) 78 (77.2 %) 23(22.8 %) 17 (44.7 %) 21 (55.3 %) <0.001
TN 66 (47.5 %) 73 (52.5 %) 46 (45.5 %) 55 (54.5 %) 20 (52.6 %) 18 (47.4 %) 0.289
LEV* 56 (40.3 %) 83 (59.7 %) 49 (48.5 %) 52 (51.5 %) 7 (18.7 %) 31 (81.6 %) 0.001
CRO* 71 (51.1 %) 68 (48.9 %) 66 (65.3 %) 35 (34.7 %) 5 (13.1 %) 33 (86.9 %) <0.001
*: significant values, AK Amikacin, SXT Trimethoprim- Sulfamethoxazole, C Chloramphenicol, TE Tetracycline, CIP Ciprofloxacin, GM Gentamicin, SPC Spectinomycin,
ATH Azithromycine, S Streptomycin, GAT Gatifloxacin, OXA Oxacillin, PG Penicillin G, RP Rifampin, LZD Linezolid, CD Clindamycin, E Erythromycin, TN Tobramycin,
LEV Levofloxacin, CRO Ceftriaxone; R Resistant, S sensitive
Mostafa et al. BMC Microbiology  (2015) 15:152 Page 3 of 9
Ciprofloxacin 51 (45.5 %), Chloramphenicol 45 (40.1 %),
Oxacillin 93 (83 %), Gatifloxacin 39 (34.8 %), Erythro-
mycin 89 (79.4 %), Azithromycin 67 (59.8 %), Tobra-
mycin 57 (50.8 %), Levofloxacin 55 (49.1 %), Rifampin
37 (33 %), Penicillin G 111 (99.1 %), Streptomycin 69
(61.6 %) and Clindamycin 73 (65.1 %). The least resist-
ance to the following antibiotics are observed:
Sulfamethoxazole-Trimethoprim 34 (30.3 %), and Linez-
olid 18 (16 %).
Detection of class 1 and 2 Integrons
One hundred and thirty-nine of S.aureus, were exam-
ined for the presence of known markers for integrons by
PCR amplification. The 101 (72.6 %) isolates were posi-
tive for class 1 integron with the amplicon size of 280 bp
and class 2 integron was found in 49 (35.2 %) isolates
with the amplicon size of 232 bp. Information about
integron positive isolates among different sources of
S.aureus isolates are shown in Table 3. In the present
study, among of 112 strains of MRSA, 95 (84.8 %) iso-
lates carrying class 1 integron as well as 46 (41 %) iso-
lates carrying class 2 integron.
The results indicate that resistance to several different
antibiotics is associated with the presence of the inte-
gron. Tables 1 and 2 shows the antibiotic susceptibilities
of integron-positive and integron-negative isolates to
each of the antibiotics. Both class 1 and 2 integrases
genes were present together in 44 (31.6 %) strains of
S.aureus.
Antimicrobial susceptibility testing showed the multi-
drug resistance rates of integron-positive class 1 and
negative strains were 72.6 % (101/139) and 27.4 % (38/
139) and also rates of integron-positive class 2 and nega-
tive strains were 35.2 % (49/139) and 64.8 % (90/139),
respectively.
Table 2 Correlation of antibiotic resistance between class 2 integron-positive and integron-negative of S. aureus
Antibiotics All strains of S.aureus (n = 139) Integron-positive isolates (n = 49) Integron-negative isolates (n = 90) P
valueR S R S R S
AK* 43 (31 %) 96 (69 %) 21 (42.9 %) 28 (57.1 %) 22 (24.4 %) 68 (75.6 %) 0.021
SXT* 38 (27.3 %) 101 (72.7 %) 24 (49 %) 25 (51 %) 14 (15.5 %) 76 (84.5 %) <0.001
C 21 (42.9 %) 28 (57.1 %) 21 (42.9 %) 28 (57.1 %) 28 (31.1 %) 62 (68.9 %) 0.116
TE* 78 (56.1 %) 61 (43.9 %) 38 (77.5 %) 11 (22.5 %) 40 (44.4 %) 50 (55.6 %) <0.001
CIP* 56 (40.3 %) 83 (59.7 %) 28 (57.1 %) 21 (42.9 %) 28 (31.1 %) 62 (68.9 %) 0.003
GM* 76 (54.7 %) 63 (45.3 %) 37 (75.5 %) 12 (24.5 %) 39 (43.3 %) 51 (56.7 %) <0.001
SPC* 86 (61.9 %) 53 (38.1 %) 41 (83.7 %) 8 (16.3 %) 45 (50 %) 45 (50 %) <0.001
ATH* 69 (49.6 %) 70 (50.4 %) 36 (73.5 %) 13 (26.5 %) 33 (36.7 %) 57 (63.3 %) <0.001
S* 75 (54 %) 64 (46 %) 34 (69.4 %) 15 (30.6 %) 41 (45.6 %) 49 (54.4 %) 0.006
GAT 44 (31.7 %) 95 (68.3 %) 19 (38.8 %) 30 (61.2 %) 25 (27.8 %) 65 (72.2 %) 0.127
OXA 104 (74.8 %) 35 (25.2 %) 41 (83.7 %) 8 (16.3 %) 63 (70 %) 27 (30 %) 0.056
PG 137 (98.6 %) 2 (1.4 %) 49 (100 %) 0 (0 %) 88 (97.8 %) 2 (2.2 %) 0.418
RP 43 (31 %) 96 (69 %) 18 (36.7 %) 31 (63.3 %) 25 (27.8 %) 65 (72.2) 0.184
LZD 24 (17.3 %) 115 (82.7 %) 9 (18.4 %) 40 (81.6 %) 15 (16.7 %) 75 (83.3 %) 0.486
CD 84 (60.4 %) 55 (39.6 %) 34 (69.4 %) 15 (30.6 %) 50 (55.6 %) 40 (44.4 %) 0.078
E* 95 (68.3 %) 44 (31.7 %) 40 (81.6 %) 9 (18.4 %) 55 (61.1 %) 35 (38.9 %) 0.01
TN 66 (47.5 %) 73 (52.5 %) 26 (53 %) 23 (47 %) 40 (44.4 %) 50 (55.6 %) 0.214
LEV* 56 (40.3 %) 83 (59.7 %) 28 (57.1 %) 21 (42.9 %) 28 (31.1 %) 62 (68.9 %) 0.003
CRO* 71 (51.1 %) 68 (48.9 %) 38 (77.5 %) 11 (22.5 %) 33 (36.7 %) 57 (63.3 %) <0.001
*: significant values AK, Amikacin, SXT Trimethoprim- Sulfamethoxazole, C Chloramphenicol, TE Tetracycline, CIP Ciprofloxacin, GM Gentamicin, SPC Spectinomycin,
ATH Azithromycine, S Streptomycin, GAT Gatifloxacin, OXA Oxacillin, PG Penicillin G, RP Rifampin, LZD Linezolid, CD Clindamycin, E Erythromycin, TN Tobramycin,
LEV Levofloxacin, CRO Ceftriaxone, R Resistant, S sensitive
Fig. 1 Distribution of mecA gene in MRSA isolates from
nosocomial sources
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Of 101 isolates carrying class 1 integrons, 89 (88.1 %)
isolates amplified class 1 integrons on chromosome, 12
(11.9 %) isolates on plasmid. Among 49 isolates har-
bored class 2 integrons, 11 (22.4 %) isolates carried class
2 integrons only on chromosome and 38 (77.6 %) iso-
lates on plasmid.
Characterization of gene cassettes in class 1 and 2
integrons
Of the 139 s.aureus isolates, 101 (72.6 %) isolates were
identified as being positive for class 1 integron. PCR
amplification of the integron cassette region occurred in
98 (97 %) class 1 integron containing isolates (Table 4).
Class 2 integron was detected in 49 (35.2 %) isolates.
The integron cassette region could not be amplified by
PCR in 17 (34.6 %) of the class 2 integron-containing
isolates (Table 5). Schematic representation of the vari-
ous cassette arrays found in class 1 and class 2 integrons
are shown in Fig. 2.
Nucleotide sequence accession numbers
The nucleotide sequence data reported in this article are
available in the GenBank nucleotide database under
GenBank accession numbers KF030468, KF411134,
KF305706, KF411137, KF411135, KF411133, KF356395,
KF305707, KJ002505, KJ002506,KF015994,KF015995,
KF411138,KF411139 obtained from the gene cassette of
class 1 integrons and KF305708, KF305710, KF411136,
KJ769139 obtained from the gene cassette of class 2
integrons, overall, 18 strains were sequenced (Table 6).
Discussion
In the current study, prevalence of intI 1 and intI 2 were
examined among multidrug resistant S.aureus strains,
isolated from different specimens. The prevalence of
antimicrobial-resistant bacterial pathogens has become a
major public health concern [16, 17]. Horizontal gene
transfer has already been proved a significant mechan-
ism for disseminating antimicrobial resistance in bacter-
ial populations. Antimicrobial drug resistance can also
be facilitated by integrons in case of many other bacteria
[18–21]. Since the integrons were detected first in
Gram-negative bacteria, many studies have been con-
ducted on Gram-negative bacteria. Although the role of
class 1integrons is well known in the spread of antibiotic
resistance genes in gram-negative bacteria, much less is
known about gram-positive bacteria and very few studies
have reported the presence of class 1 integrons in gram-
positive bacteria so increasing antibiotic resistance medi-
ated by integrons in gram-positive bacteria has become
a great concern in the medical field [22].
Integrons are genetic elements able to recognize and
capture mobile gene cassettes carrying antibiotic resist-
ance genes leading to MDR distribution and subsequently
limitation of treatment options for infections [23].
To our knowledge, this is the first study to report carriage
of class 1 and 2 integrons and associated gene cassettes in
S.aureus isolates from Iran. Our findings demonstrate that
Table 3 Information about integron positive isolates among













Blood (31) 24 11 10
Catheter (5) 3 3 3
CSF (1) 1 0 0
Eye (2) 2 0 0
Nasal (21) 14 1 1
Sputum (4) 2 3 2
Sternum (5) 2 0 0
Throat (3) 2 3 2
Urine (28) 25 11 11
Wound (31) 22 14 12
Synovia (1) 0 0 0
Total (139) 101 (72.6 %) 49 (35.2 %) 44 (31.6 %)
Table 4 Sizes of variable regions of integron class I cassettes in
intI1 positive isolates










Without PCR product 3 (2.9)
Total no. of intI1 positive isolates 101 (100)
Table 5 Sizes of variable regions of integron class 2 cassettes
inintI2 positive isolates




Without PCR product 17 (34.6)
Total no. of intI2 positive isolates 49 (100)
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integrons are widespread among S.aureus clinical isolates in
Tehran. Most resistant pattern was observed in amoxicillin,
ampicillin, oxacillin, erythromycin, tetracycline, gentamicin,
tobramycin, streptomycine, spectinomycin, ciprofloxacin,
azithromycine, penicillin G, clindamycin, levofloxacin, cef-
triaxone and antibiotic such as vancomycin, teicoplanin,
linezolid and trimethoprim-sulfamethoxazole were consid-
ered as the most effective drugs against S.aureus strains that
this results largely agrees to findings of Xu et al. about
amoxicillin/clavulanic acid, ciprofloxacin, clindamycin,
erythromycin, gentamicin, levofloxacin, oxacillin, tetra-
cycline, trimethoprim-sulfamethoxazole and the result
of Ren et al. about oxacillin, erythromycin, azithromy-
cin, clindamycin, amoxicillin/clavulanic acid, ciproflox-
acin, tetracycline, gentamycin [24, 25].
Among different classes of integrons, class 1 inte-
grons have been found more frequently in different
species of bacteria, especially Gram-negative bacteria
[11, 26, 27]. The classification of different integrons is
mainly based on differences in the gene structure of
integrases [11].
In this survey, presence of integrons in strains of
S.aureus as compared to similar studies conducted by
Xu et al. and Ren et al. has been increased [24, 25]. The
rate of detection of integron class 1 was more than inte-
gron class 2. One hundred and one (72.6 %) isolates
were positive for class 1 integron and 49 (35.2 %) isolates
were positive for class 2 integron.
The nine different cassettes arrangements wich class 1
integrons and another three arrangements within class 2
integrons were identified.
Twelve different gene cassettes were detected. Cassette
genes encoding resistance to aminoglycosides were
found to be predominant in the class 1 integron. The
aadB and aadA types genes that encode resistance to
aminoglycosides (aadB gene cassette conferring resist-
ance to gentamicin, tobramycin, and kanamycin; aadA
gene cassette conferring resistance to streptomycin and
spectinomycin) were most commonly found [11].
The B-lactamase cassettes (oxa2 or blaoxa2) that con-
fer resistance to oxacillin and ampicillin [28], were found
in three isolates with amplicon size 1200 bp. The aacA4
cassette (aminoglycoside acetyl transferase) that confer
resistance to gentamicin, amikacin and tobramycin, was
found with amplicon size 800 bp [11, 28].
The dfr cassettes (dfrA1,-A11) that confer resistance to
trimethoprim, were also detected frequently. The sat2
cassette confers resistance to streptothricin by encoding
a streptothricin acetyltransferase [28, 29].
The diversity of gene cassettes inserted in IVRs of
class 2 integrons is much lower than class 1 integrons.
This reduction in diversity is probably owing to a non-
sense mutation in codon 179 (ochre 179) in the inte-
grase gene of class 2 integrons, thereby yielding a
truncated, non-functional protein, the resultant inte-
grase is therefore unable to excise existing cassettes or
insert new ones [10].
Phenotypic and genotypic characterizations of
integrase-positive S.aureus are shown in Table 6. Ninety
percent (91 out of 101) of class 1 and 8.16 % (4 out of 49)
of class 2 integrons harboured at least one gene cassette.
Eleven arrays were detected containing one to three cas-
settes, out of which eight distinct arrays were present in
integrons of class 1 and three arrays in class 2 integrons.
Common gene cassettes arrays were identified in S.aureus
strains. In comparison with other sequences deposited in
databases, the following gene cassettes were identified:
gentamicin, tobramycin and kanamycin resistance genes
(aadB), gentamicin, amikacin and tobramycin resistance
genes (aacA4), streptomycin and spectinomycin resistance
genes (aadA1, aadA2), trimethprim resistance genes
(dfrA1, dfrA11), β-lactam resistance genes (blaoxa2),
chloramphenicol resistance genes (catB3, catB8 and
cmlA6), streptothricin resistance genes (sat2), an orfD en-
coding a protein with unknown function, a putative
Fig. 2 Schematic representation of the various cassette arrays found
in class 1 and class 2 integrons. The arrows display the open reading
frames of the different genes. All aadA and aadB genes are
presented as white arrows, dhfrA, aacA4, orfD, oxa2, catB, cmlA6, sat2
genes are presented as black, yellow, light grey, grey, blue and light
blue arrows respectively. The grey light boxes indicate the 3′ and 5′
CSs of class1 or class 2 integrons
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glucose dehydrogenase. Moreover, the arrays aadB and
aadA2 in class 1 integrons were found during the entire
process, indicating the most common array. Previous
studies have reported aadA2, aacA4-cmlA1, dfrA17-
aadA5 and dfrA12-orfF-aadA2 genes as frequently
found gene cassettes both in clinical and environmental
strains [30, 31].
Common gene cassette arrangements in class 2 integrons
were found in S.aureus strains (dfrA1-sat2-aadA1). It
should be noted, the cassette array dfrA1-sat2-aadA1 was
detected most frequently in class 2 integrons [15, 30–32].
Furthermore, integron-positive isolates were resistant to
different classes of antimicrobial agents but related re-
sistance gene cassettes were not found to be harbored
on the integron, implying the nonintegron sources of re-
sistance to these antibiotics [33]. In this study, integron
cassette region could not be amplified by PCR in 3
(2.9 %) and 17 (34.6 %) of the class 1 and 2 integron-
containing isolates respectively. In the cases where the
cassette array could not be amplified, there is no cas-
settes or in the absent, significant alter-ation in the 3 CS
primer binding site or a very large size of the Integron
cassette are the most likely explanations for the negative
PCRs [3].
The total prevalence of integrases carried in plasmids
36 % (50/139) was similar to that previously reported in
S.aureus [34]. Nevertheless, we are aware that the preva-
lence obtained may be biased due to the fact that plas-
mid and chromosomal DNA can display the same
electrophoretic mobility. The dissemination of the class
1 integrons, in many instances, has been attributed to
the spread of an integron-containing transposon, Tn21
[35]. The distribution of Tn7 in clinical isolates corre-
lates with the frequency of trimethoprim resistance [36].
Trimethoprim resistance is due to the dihydrofolate re-
ductase enzyme encoded by the dhfr gene in Tn7 [29].
Class 2 integron variable regions were amplified using
primers that bind to attI2 and to orfX, situated down-
stream of the cassette region within transposon Tn7
[37]. Therefore, the presence of such an integron in
S.aureus may have had its origin in a transposition
event.
Table 6 Phenotypic and genotypic characterization of isolates by different length of amplicons









Sm59 wound 1200 bp I blaoxa2 C CRO,LEV,TN,E,CD,LZD,RP,PG,OXA,A,S,ATH,GM,CIP,AP,SXT KF356395
MMS1 wound 750 bp I aadB C CRO,E,CD,PG,A,S,ATHSPC,GM,CIP,AP,TE,C,AK KF015994
s61 wound 750 bp I aadB C CRO,TN,E,CD,PG,OXA,A,S,SPC,GM,CIP,AP,TE,SXT KF030468
sm54 blood 1200 bp I blaoxa2 C CRO,LEV,TN,E,CD,LZD,RP,PG,OXA,A,S,ATH,GM,CIP,AP,SXT KF305707
sa10 blood 800 bp I aacA4 C CRO,LEV,E,CD,LZD,RP,PG,OXA,A,S,ATH,CIP,AP,TE,SXT KF305706





MMS2 abscess 750 bp I aadB C CRO,E,CD,PG,A,S,ATH,SPC,GM,CIP,AP,TE,C,AK KF015995
s74 blood 1000 bp I aadA2 C CRO,TN,E,CD,PG,OXA,A,S,SPC,GM,CIP,AP,TE,SXT KF411134
s54 blood 2120 bp I orfD-aacA4-catBB P CRO,LEV,E,CD,LZD,PG,OXA,A,S,ATH,SPC,GM,CIP,AP,TE,C,AK KF411135
s5 wound 1100 bp I orfD-aacA4 C CRO,LEV,E,CD,LZD,PG,OXA,A,S,ATH,SPC,GM,CIP,AP,TE,C,AK KF411137
s22 wound 1000 bp I aadA2 C CRO,TN,E,CD,PG,OXA,A,S,SPC,GM,CIP,AP,TE,SXT,AK KF411138
s36 blood 1000 bp I aadA2 C CRO,TN,E,CD,PG,OXA,A,S,SPC,GM,CIP,AP,TE,SXT KF411139
sm91 blood 1420 bp I aadB-catB3 C CRO,TN,E,CD,PG,OXA,A,S,SPC,GM,APC,SXT KJ002505
sm105 wound 3100 bp I aadB-aadA1-cmlA6 P CRO,LEV,E,CD,LZD,PG,OXA,A,S,ATH,SPC,GM,CIP,AP,TE,C,SXT,AK KJ002506
sm22 wound 750 bp II hdfrA11 C CRO,LEV,TN,E,CD,PG,OXA,A,S,SPC,GM,CIP,AP,TE,SXT KF305708
sm97 blood 2500 bp II dhfrA1-sat2-aadA1 P CRO,LEV,TN,E,CD,PG,OXA,GAT,A,S,ATH,SPC,GM,CIP,AP,TE,C,SXT,AK KF305710
s92 blood 750 bp II hypothetical
protein
C CRO,E,CD,PG,OXA,AS,SPC,AP,TE KF411136
s105 wound 1230 bp II dhfrA1-sat2 C CRO,LEV,TN,E,CD,LZD,RP,PG,OXA,A,S,ATH,GM,AP,SXT KJ769139
a c chromosomal location, P plasmid location, CRO ceftriaxone, LEV levofloxacin, E erythromycin, CD clindamycin, TN tobramycin, PG penicillin G, LZD linezolid, OXA
oxacillin, A amoxicillin, S streptomycin, ATH azithromycine, SPC spectinomycin, GM gentamycin, CIP ciprofloxacin, AP ampicillin, TE tetracycline, C chloramphenicol,
SXT trimethoprim-sulfamethoxazole, AK amikacin
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Antimicrobial resistance patterns revealed that
78.4 % of the integrase-positive strains were multire-
sistant (i.e. resistant to 3 or more antibiotics).
Conclusions
This is the first report of the presence of classes 1 and 2
integrons in isolates of S.aureus in Iran. These results
indicated with the spread of MDR strains, class 1 and 2
integrons carrying gene cassettes are widely dissemi-
nated among S.aureus strains in our hospital. In cases
that significant relationship between the presence of
integrons and antibiotic resistance were not observed,
resistance could be achieved by different ways such as
deficiency in cell wall enzymes or resistance under plas-
mid or chromosome control [38].
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